Trichuris suis secrete products that reduce disease severity in a multiple sclerosis model

Christine Søholm Hansen; Henrik Hasseldam; Idahella Hyldgaard Bacher; Stig Milan Thamsborg; Flemming Fryd Johansen; Helene Kringel

doi:10.1515/ap-2017-0002

Article

Trichuris suis secrete products that reduce disease severity in a multiple sclerosis model

Christine Søholm Hansen , Henrik Hasseldam , Idahella Hyldgaard Bacher , Stig Milan Thamsborg , Flemming Fryd Johansen and Helene Kringel

Published/Copyright: December 28, 2016

Published by

Become an author with De Gruyter Brill

Author Information

From the journal Acta Parasitologica Volume 62 Issue 1

Abstract

Multiple sclerosis is a chronic inflammatory central nervous system (CNS) disease, which affects about 1 in 1000 individuals in the western world. It has been suggested that this relatively high prevalence is linked to a high level of hygiene, i.e. a reduced exposure to various microorganisms, including parasites. Parasites are known to employ different immunomodulatory and antiinflammatory strategies, which enable them to evade destruction by the immune system. We have investigated the immunomodulation by the swine whipworm, Trichuris suis, by measuring the impact of oral administration of T. suis ova as well as of intraperitoneal administration of T. suis excretory/secretory products on the development and progression of experimental autoimmune encephalomyelitis – an animal model that shares clinical and pathological characteristics with multiple sclerosis. Intraperitoneal administration of excretory/secretory products before disease onset, resulted in a significant decrease in disease severity as well as markedly reduced T_H1 and T_H17 T-cell responses, centrally in the spinal cord as well as in the periphery, i.e. the spleen. Thus, parenteral administration of T. suis-derived products results in a skewing of the immune response with a significant impact on disease severity in a CNS inflammatory disease model.

Keywords: Trichuris suis; multiple sclerosis; immunomodulation; t-cells

Acknowledgements

We acknowledge the late Dr. A. Roepstorff for his inspiration and contribution to this project. The work was supported by the Danish Multiple Sclerosis Society. H. Hasseldam, S. M. Thamsborg, F. F. Johansen, H. Kringel and A. Roepstorff participated in designing the study; C. S. Hansen, I. H. Bacher, H. Hasseldam and H. Kringel performed the research and H. Hasseldam, C.S. Hansen and H. Kringel wrote the manuscript. All authors read and approved the final manuscript.

References

Beer R.J. 1973. Studies on the biology of the life-cycle of Trichuris suis Schrank, 1788. Parasitology, 67, 253–26210.1017/S0031182000046497Search in Google Scholar

Compston A., Coles A. 2002. Multiple sclerosis. Lancet, 359, 1221–1231. 10.1016/s0140-6736(02)08220-xSearch in Google Scholar

Correale J., Farez M.F. 2011. The impact of parasite infections on the course of multiple sclerosis. Journal of Neuroimmunology,233, 6–11. dx.doi.org/10.1016/j.jneuroim.2011.01.002Search in Google Scholar

Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 421, 744–748. dx.doi.org/10.1038/nature0135Search in Google Scholar

Fleming J.O., Cook T.D. 2006. Multiple sclerosis and the hygiene hypothesis. Neurology, 67, 2085–2086. dx.doi.org/ 10.1212/01.wnl.0000247663.40297Search in Google Scholar

Fleming J.O., Isaak A., Lee J., Luzzio C., Carrithers M., Cook T.D., et al. 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis, 17, 743–754. dx.doi.org/10.1177/1352458511398054.2dSearch in Google Scholar

Fleming J.O., Hartman L., Maksimovic J., Nace S., Luzzio C., Koehn M., et al. 2014. Clinical Trial of Helminth-induced Immunomodulatory Therapy (HINT 2) in Relapsing-Remitting Multiple Sclerosis (P3.149). Neurology, 82, p3.149Search in Google Scholar

Gruden-Movsesijan A., Ilic N., Mostarica-Stojkovic M., Stosic-Grujicic S., Milic M. Sofronic-Milosavljevic L. 2008. Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats. Experimental Parasitology,118, 641–647. 10.1016/j.exppara.2007.12.003Search in Google Scholar PubMed

Gruden-Movsesijan A., Ilic N., Mostarica-Stojkovic M., Stosic-Grujicic S., Milic M., Sofronic-Milosavljevic L. 2010. Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunology, 32, 450–459. dx.doi.org/10.1111/j.1365-3024.2010.01207.xSearch in Google Scholar

Hasseldam H., Ilic N., Mostarica-Stojkovic M., Stosic-Grujicic S., Milic M., Sofronic-Milosavljevic L. 2013. Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis. Parasite Immunology, 35, 103–108.10.1111/pim.12023Search in Google Scholar PubMed

Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., et al. 2007. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nature Medicine, 13, 1173–1175. 10. 1038/nm1651Search in Google Scholar

Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., et al. 2009. Preferential recruitment of interferon-gammaexpressing TH17 cells in multiple sclerosis. Annals of Neurology, 66, 390–402. 10.1002/ana.21748Search in Google Scholar PubMed

Klaver E.J., Kuijk L.M., Laan L C., Kringel H., van Vliet S.J., Bouma G., et al. 2013. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated. International Journal for Parasitology, 43, 191–200. 10.1016/j.ijpara. 2012.10.021Search in Google Scholar

Kuijk L.M., Klaver E.J., Kooij G., van der Pol S.M., Heijnen P., Bruijn, S.C., et al. 2012. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Molecular Immunology, 51, 210–218. dx.doi.org/10.1016/j.molimm.2012.03.020Search in Google Scholar

La Flamme A.C., Ruddenklau K., Backstrom B.T. 2003. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infection and Immunity, 71,4996–5004. dx.doi.org/10.1128/IAI.71.9.4996-5004.2003Search in Google Scholar

Lightowlers M.W., Rickard M.D. 1988. Excretory-secretory products of helminth parasites: effects on host immune responses. Parasitology, 96 Suppl, S123–166. dx.doi.org/10.1017/S0031182000086017Search in Google Scholar

Milo R., Kahana E. 2010. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmunity Reviews, 9, A387–394. 10.1016/j.autrev.2009.11.01014Search in Google Scholar

Owens T., Wekerle H., Antel J. 2001. Genetic models for CNS inflammation. Nature Medicine, 7, 161–166. 10.1038/84603Search in Google Scholar PubMed

Rook G.A. 2012. Hygiene hypothesis and autoimmune diseases. Clinical Reviews in Allergy and Immunology, 42, 5–15. 10.1007/s12016-011-8285-8Search in Google Scholar PubMed

Sewell D., Qing Z., Reinke E., Elliot D., Weinstock J., Sandor M., Fabry Z. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. International Immunology, 15, 59–69. dx.doi.org/10.1093/intimm/dxg012Search in Google Scholar

Strachan D.P. 1989. Hay fever, hygiene, and household size. British Medical Journal, 299, 1259–1260. dx.doi.org/10.1136/bmj.299.6710.1259Search in Google Scholar

Summers R.W., Elliott D.E., Urban J.F. Jr., Thompson R., Weinstock J.V. 2005a. Trichuris suis therapy in Crohn’s disease. Gut, 54, 87–90. dx.doi.org/10.1136/gut.2004.041749Search in Google Scholar

Summers R.W., Elliott D.E., Urban J.F. Jr., Thompson R.A., Weinstock J V. 2005b. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology, 128, 825–832. dx.doi.org/10.1053/j.gastro.2005.01.005Search in Google Scholar

Voldsgaard A., Bager P., Garde E., Akeson P., Leffers A.M., Madsen C.G. 2015. Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect. Multiple Sclerosis, 21, 1723–1729.10.1177/1352458514568173Search in Google Scholar PubMed

Walsh K.P., Brady M.T., Finlay C.M., Boon L., Mills K.H. 2009. Infection with a helminth parasite attenuates autoimmunity through TGFbeta-mediated suppression of Th17 and Th1 responses. Journal of Immunology, 183, 1577–158610.4049/jimmunol.0803803Search in Google Scholar PubMed

Wu Z., Nagano I., Asano K., Takahashi Y 2010. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Parasitology Research, 107, 1173–1188. dx.doi.org/10.1007/s00436-010-1985-9Search in Google Scholar

Zheng X., Hu X., Zhou G., Lu Z., Qiu W., Bao J., Dai Y. 2008. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. Journal of Neuroimmunology, 194, 107–114. dx.doi.org/10.1016/ j.jneuroim.2007.12.001Search in Google Scholar

Received: 2016-4-1

Revised: 2016-8-11

Accepted: 2016-9-1

Published Online: 2016-12-28

Published in Print: 2017-3-1

You are currently not able to access this content.

Articles in the same Issue

https://doi.org/10.1515/ap-2017-0002

Keywords for this article

Trichuris suis; multiple sclerosis; immunomodulation; t-cells